Granulocyte colony-stimulating factor promotes adhesion of neutrophils

被引:37
作者
Chakraborty, A
Hentzen, ER
Seo, SM
Smith, CW
机构
[1] Baylor Coll Med, Dept Med, Infect Dis Sect, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Pediat, Sect Leukocyte Biol, Houston, TX 77030 USA
[3] Rice Univ, Dept Biomed Engn, Houston, TX 77030 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY | 2003年 / 284卷 / 01期
关键词
granulocyte colony-stimulating factor; intracellular adhesion molecule-1; leukocyte function-associated antigen-1; macrophage antigen-1; adhesion; polymorphonuclear neutrophils;
D O I
10.1152/ajpcell.00165.2002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Granulocyte colony stimulating factor (G-CSF) is well known for its ability to drive the maturation and mobilization of neutrophils. G-CSF also appears to have the potential to activate functions of mature neutrophils, influencing recruitment at sites of inflammation and tissue injury. We investigated the ability of G-CSF to stimulate adhesion of isolated blood neutrophils. G-CSF induced significant adherence to intercellular adhesion molecule (ICAM)-1 that was both macrophage antigen-1 (Mac-1) and leukocyte function-associated antigen-1 dependent. The kinetics of G-CSF-stimulated adhesion to ICAM-1 peaked at 11 min without detectable surface upregulation of Mac-1. This was in marked contrast to chemokines, in which peak activation of adhesion is seen within 1 min of stimulation. In contrast to chemokine-induced adhesion, G-CSF stimulation was not inhibited by pertussis toxin. G-CSF also augmented the attachment of neutrophils to activated human umbilical vein endothelial cells (HUVEC) through specific effects on neutrophils, because HUVEC appear to lack functional G-CSF receptors.
引用
收藏
页码:C103 / C110
页数:8
相关论文
共 50 条
[21]   Serum granulocyte colony-stimulating factor levels in gliomas [J].
Yildiz, R. ;
Coskun, U. ;
Buyukberber, S. ;
Sancak, B. ;
Kaya, A. O. ;
Gulbahar, O. ;
Benekli, M. .
JOURNAL OF BUON, 2011, 16 (01) :138-141
[22]   Granulocyte colony-stimulating factor use in cancer patients [J].
Baker, J ;
McCune, JS ;
Harvey, RD ;
Bonsignore, C ;
Lindley, CM .
ANNALS OF PHARMACOTHERAPY, 2000, 34 (7-8) :851-857
[23]   Granulocyte colony-stimulating factor is not pathogenic in lupus nephritis [J].
Gottschalk, Timothy A. ;
Vincent, Fabien B. ;
Hoi, Alberta Y. ;
Hibbs, Margaret L. .
IMMUNITY INFLAMMATION AND DISEASE, 2021, 9 (03) :758-770
[24]   RECENT DEVELOPMENTS IN THE CELL BIOLOGY OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND GRANULOCYTE COLONY-STIMULATING FACTOR - ACTIVITIES ON ENDOTHELIAL-CELLS [J].
BUSSOLINO, F ;
COLOTTA, F ;
BOCCHIETTO, E ;
GUGLIELMETTI, A ;
MANTOVANI, A .
INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH, 1993, 23 (01) :8-12
[25]   Modulation of neutrophil apoptosis by granulocyte colony-stimulating factor and granulocyte/macrophage colony-stimulating factor during the course of acute respiratory distress syndrome [J].
Matute-Bello, G ;
Liles, WC ;
Radella, F ;
Steinberg, KP ;
Ruzinski, JT ;
Hudson, LD ;
Martin, TR .
CRITICAL CARE MEDICINE, 2000, 28 (01) :1-7
[26]   Granulocyte colony-stimulating factor serum and urine concentrations in neutropenic neonates before and after intravenous administration of recombinant granulocyte colony-stimulating factor [J].
Calhoun, DA ;
Lunoe, M ;
Du, Y ;
Hutson, AD ;
Veerman, M ;
Christensen, RD .
PEDIATRICS, 2000, 105 (02) :392-397
[27]   Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy [J].
Wong, SF ;
Chan, HO .
PHARMACOTHERAPY, 2005, 25 (03) :372-378
[28]   The role of haematopoietic growth factors granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the management of drug-induced agranulocytosis [J].
Andres, Emmanuel ;
Maloisel, Frederic ;
Zimmer, Jacques .
BRITISH JOURNAL OF HAEMATOLOGY, 2010, 150 (01) :3-8
[29]   Paclitaxel, ifosfamide and cisplatin with granulocyte colony-stimulating factor or recombinant human interleukin 3 and granulocyte colony-stimulating factor in ovarian cancer: A feasibility study [J].
Veldhuis, GJ ;
Willemse, PHB ;
Beijnen, JH ;
Boonstra, H ;
Piersma, H ;
vanderGraaf, WTA ;
deVries, EGE .
BRITISH JOURNAL OF CANCER, 1997, 75 (05) :703-709
[30]   CLINICAL EFFECT OF GRANULOCYTE COLONY-STIMULATING FACTOR ON NEUTROPHILS AND LEUKEMIC-CELLS IN MYELOGENOUS LEUKEMIA - ANALYSIS [J].
ISHIKAWA, J ;
YOSHIMURA, M ;
MATSUNASHI, T ;
TOMINAGA, N ;
TESHIMA, H ;
HIRAOKA, A ;
NAKAMURA, H ;
SHIBATA, H ;
MASAOKA, T ;
TAKAKU, F .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1991, 21 (03) :169-175